MDX-22-treated bone marrow data

Results from 138 patients in an ongoing Phase II trial show that

Read the full 120 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE